Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
School of Medicine, University of Tunis El Manar, Tunis, Tunisia.
Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021.
Neoplasms of the peripheral nervous system represent a heterogenous group with a wide spectrum of morphological features and biological potential. They range from benign and curable by complete excision (schwannoma and soft tissue perineurioma) to benign but potentially aggressive at the local level (plexiform neurofibroma) to the highly malignant (malignant peripheral nerve sheath tumors [MPNST]). In this review, we discuss the diagnostic and pathologic features of common peripheral nerve sheath tumors, particularly those that may be encountered in the intracranial compartment or in the spine and paraspinal region. The discussion will cover schwannoma, neurofibroma, atypical neurofibromatous neoplasms of uncertain biological potential, intraneural and soft tissue perineurioma, hybrid nerve sheath tumors, MPNST, and the recently renamed enigmatic tumor, malignant melanotic nerve sheath tumor, formerly referred to as melanotic schwannoma. We also discuss the diagnostic relevance of these neoplasms to specific genetic and familial syndromes of nerve, including neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis. In addition, we discuss updates in our understanding of the molecular alterations that represent key drivers of these neoplasms, including neurofibromatosis type 1 and type 2, SMARCB1, LZTR1, and PRKAR1A loss, as well as the acquisition of CDKN2A/B mutations and alterations in the polycomb repressor complex members (SUZ12 and EED) in the malignant progression to MPNST. In summary, this review covers practical aspects of pathologic diagnosis with updates relevant to neurosurgical practice.
外周神经系统肿瘤是一组具有广泛形态特征和生物学潜能的异质性肿瘤。它们的范围从可通过完全切除治愈的良性肿瘤(神经鞘瘤和软组织神经鞘瘤)到良性但局部侵袭性较高的肿瘤(丛状神经纤维瘤),再到高度恶性的肿瘤(恶性外周神经鞘瘤[MPNST])。在这篇综述中,我们讨论了常见外周神经鞘瘤的诊断和病理特征,特别是那些可能在颅内或脊柱和脊柱旁区域遇到的肿瘤。讨论将涵盖神经鞘瘤、神经纤维瘤、生物学潜能不确定的非典型神经纤维瘤性肿瘤、神经内和软组织神经鞘瘤、混合性神经鞘瘤、MPNST 以及最近重新命名的神秘肿瘤,恶性黑色素性神经鞘瘤,以前称为黑色素性神经鞘瘤。我们还讨论了这些肿瘤与特定的神经遗传和家族综合征的诊断相关性,包括神经纤维瘤病 1 型、神经纤维瘤病 2 型和神经鞘瘤病。此外,我们还讨论了我们对这些肿瘤关键驱动因素的分子改变的理解的最新进展,包括神经纤维瘤病 1 型和 2 型、SMARCB1、LZTR1 和 PRKAR1A 缺失,以及 CDKN2A/B 突变的获得和多梳抑制复合物成员(SUZ12 和 EED)在外周神经鞘瘤恶性进展中的改变。总之,这篇综述涵盖了与神经外科实践相关的病理诊断的实用方面。